Bladder Cancer

Bladder cancer is the fifth most common cancer with an estimated 60,490 new cases and 12,240 deaths expected for 2017 in the US alone. The diagnosis and treatment of bladder cancer in the current era is in the midst of a revolution. Recent research has focused on the evaluation of genetic markers to provide diagnostic and prognostic information in bladder cancer. In recent years, systemic therapies using a variety of immunotherapeutic strategies have evolved for the treatment of urothelial carcinoma. Bladder Cancer: Research Advances and Clinical Challenges is a textbook on bladder cancer written by leading world experts in the field. This new book presents the latest research in this field. It has ten chapters that discuss a wide variety of the most important topics, including: cancer stem cells; molecular biomarkers; cancer detection and monitoring; clinical prognostication; immune checkpoint inhibitors; etc. It will equally be appreciated by urologists as well as scientists. The editor hopes that this book will offer the most contemporary and useful information for specialists involved in bladder cancer.